Amarantus BioScience, Inc. (OTCQB:
AMBS) published a new blog post on The Chairman's Blog, written by
the company's President and CEO, Gerald E. Commissiong.
TheChairmansBlog.com is an exclusive online media publication that
enables key executive officers a unique platform to share insights
about their company and industry trends.
President and CEO, Gerald E. Commissiong, writes about the company's
announced second closing of a previously announced private placement
offering. He writes about "key fundamental value-building steps"
Amarantus is taking as it moves towards a possible up-listing to a
national exchange. Read the full blog post from Gerald Commissiong
About Amarantus BioScience, Inc.
AmarantusBioScience, Inc. is a
development-stage biotechnology company founded in January 2008. The
Company has a focus on developing certain biologics surrounding the
intellectual property and proprietary technologies it owns to treat
and/or diagnose Parkinson's disease, Traumatic Brain Injury and
other human diseases. The Company owns the intellectual property
rights to a therapeutic protein known as
Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and
is developing MANF-based products as treatments for brain disorders.
The Company also is a Founding Member of the Coalition for Concussion
Treatment (#C4CT), a movement initiated in collaboration with Brewer
Sports International seeking to raise awareness of new treatments in
development for concussions and nervous-system disorders. For further
information, please visit http://www.amarantus.com/.
an exclusive, online media publication where publically and
privatively held firms alike share insights about their companies and
industries. TheChairmansBlog.com enables upper tier management to
discuss issues that are of importance to their stakeholders,
shareholders, and interested parties in an informal environment. In
addition to management's insightful blog posts, TheChairmansBlog.com
staff and aggregate partners contribute articles on finance,
technology, health, and energy while providing updated market trends,
news, and information.
Leave a comment...